This application proposes continued funding of the Harvard University Center for AIDS Research (HU CFAR). HU CFAR represents each of the Harvard affiliated schools and hospitals, including Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Children's Hospital Boston, the Immune Disease Institute, Massachusetts General Hospital, Brigham & Women's Hospital, Lemuel Shattuck Hospital, and the
New England Primate Research Center. HU CFAR's goals are: 1) to consolidate and expand existing collaborations among the diverse and highly successful HU-affiliated HIV/AIDS researchers, 2) to promote new interactions and innovative research initiatives capable of more effectively addressing key AIDS research questions and 3) to attract and support the next generation of young scientists into HIV research.
HU CFAR builds collaborations and provides infrastructure support to coordinate and address emerging research opportunities in basic, clinical, behavioral, and translational AIDS activities. Research emphasis among investigators includes studies of molecular virology, pathogenesis, host immune responses, epidemiology, treatment, vaccines and prevention. CFAR funding will provide administrative resources to address the most significant scientific questions in AIDS in six identified Scientific Programs: Behavioral and
Social Sciences, Clinical Epidemiology and Outcomes Research, International, Pathogenesis, Therapeutics, and Vaccines. Five core facilities have also been identified for continued HU CFAR support: Clinical, Molecular Virology/Genomics, Immunology, Biostatistics, and Small Animal Containment. In addition, the Administrative Core will provide strategic planning and fiscal oversight; the Developmental Core will support innovative pilot projects related to the goals of the scientific programs.
HU CFAR will continue to expand, promote, and facilitate collaborative, multidisciplinary activities in AIDS research among CFAR members as the Harvard University model for collaborative inter-institutional interactions. Future planned activities include the development of junior investigators, expansion of the Behavioral and Social Sciences Program, development of the Molecular Virology/Genomics Core facilities,
expansion of access to international clinical specimens, expansion of international research and educational activities, community outreach activities and further collaborations with other CFARs.
Public Health Relevance Statement
The HU CFAR is a comprehensive Center providing the infrastructure to integrate Harvard University's multidisciplinary AIDS-related clinical and basic research programs. This provides a unique platform to maximize the contribution to public health by Harvard's HIV/AIDS investigators
National Institute of Allergy and Infectious Diseases
CFDA Code
701
DUNS Number
082359691
UEI
LN53LCFJFL45
Project Start Date
16-August-2010
Project End Date
15-August-2012
Budget Start Date
16-August-2010
Budget End Date
15-August-2012
Project Funding Information for 2010
Total Funding
$134,000
Direct Costs
$100,000
Indirect Costs
$34,000
Year
Funding IC
FY Total Cost by IC
2010
National Institute of Allergy and Infectious Diseases
$134,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3P30AI060354-07S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P30AI060354-07S1
Patents
No Patents information available for 3P30AI060354-07S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P30AI060354-07S1
Clinical Studies
No Clinical Studies information available for 3P30AI060354-07S1
News and More
Related News Releases
No news release information available for 3P30AI060354-07S1
History
No Historical information available for 3P30AI060354-07S1
Similar Projects
No Similar Projects information available for 3P30AI060354-07S1